Dermapharm Holding SE (DMPHF) Q3 2025 Earnings Report
DMPHF Q3 2025 EPS Results
- Actual EPS
- $0.85
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- $0.67
DMPHF Q3 2025 Revenue Results
- Actual Revenue
- $330.46M
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- -5.36%
Earnings Announcement Details
- Quarter
- Q3 2025
- Date
- 11/13/2025
- Time
- Before Open
- Conference Call
- Thursday, November 13, 2025
DMPHF Upcoming Earnings
Dermapharm Holding SE's next earnings date is estimated for November 12, 2026, based on past reporting schedules.
Q3 2025 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2025 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2025 Earnings Call Summary
No earnings call summary is available for this earnings event.
DMPHF Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 12, 2026 | 2026 (Q3) | ―- | 0.85 | ― | ― |
| Aug 25, 2026 | 2026 (Q2) | 0.530.53 | 0.44 | 20.51% (+0.09) | |
| May 13, 2026 | 2026 (Q1) | ―0.94 | 0.69 | 35.48% (+0.25) | |
| Mar 10, 2026 | 2025 (Q4) | 0.460.81 | 0.43 | 89.47% (+0.38) | |
| Nov 13, 2025 | 2025 (Q3) | ―0.85 | 0.67 | 26.67% (+0.18) | |
| Aug 26, 2025 | 2025 (Q2) | ―0.44 | 0.36 | 21.88% (+0.08) | |
| May 15, 2025 | 2025 (Q1) | ―0.69 | 0.91 | -23.46% (-0.21) | |
| Mar 14, 2025 | 2024 (Q4) | ―0.43 | -0.06 | 860.00% (+0.48) | |
| Nov 14, 2024 | 2024 (Q3) | ―0.67 | 0.52 | 30.43% (+0.16) | |
| Aug 27, 2024 | 2024 (Q2) | ―0.36 | -0.19 | 288.24% (+0.55) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed